You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RP

Showing 1 - 25 of 8,710
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Ovarian Cancer, Recurrent Uterine Cancer, Metastatic Cancer Trial in Toronto (RP-6306, Carboplatin, Paclitaxel)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Oct 25, 2023

Advanced Cancer Trial (RP-6306, Gemcitabine, FOLFIRI Protocol)

Not yet recruiting
  • Advanced Cancer
  • (no location specified)
Jan 9, 2023

Healthy Trial in Taichung (rice protein RP-80N, )

Active, not recruiting
  • Healthy
  • rice protein RP-80N
  • placebo
  • Taichung, Taiwan
    Chung Shan Medical University
Nov 25, 2022

Squamous Cell Carcinoma, RP1 Trial (RP1)

Not yet recruiting
  • Squamous Cell Carcinoma
  • RP1
  • (no location specified)
May 4, 2023

Danon Disease Trial in La Jolla, Philadelphia (RP-A501)

Recruiting
  • Danon Disease
  • RP-A501
  • La Jolla, California
  • +1 more
Oct 17, 2023

Nephrectomy, Prostatectomy Trial in Barcelona (Robot assisted laparoscopic Radical/simple nephrectomy (RN), Partial nephrectomy

Recruiting
  • Nephrectomy
  • Prostatectomy
  • Robot assisted laparoscopic Radical/simple nephrectomy (RN), Partial nephrectomy (PN) or Radical Prostatectomy (RP).
  • Barcelona, Spain
    Hospital Clínic de Barcelona
Nov 6, 2023

PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM) Trial in La Jolla, Philadelphia (RP-A601)

Not yet recruiting
  • PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
  • RP-A601
  • La Jolla, California
  • +1 more
May 22, 2023

Triple Negative Breast Tumors Trial in Paris (Atezolizumab + RP1)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Atezolizumab + RP1
  • Paris, France
    Institut Curie
Oct 2, 2023

Chronic Lymphocytic Leukemia Trial in Salt Lake City (RP-3500 in combination with Olaparib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • RP-3500 in combination with Olaparib
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Sep 23, 2022

Locally Advanced Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial (RP3,

Not yet recruiting
  • Locally Advanced Hepatocellular Carcinoma
  • +2 more
  • RP3
  • +2 more
  • (no location specified)
Feb 8, 2023

Retinitis Pigmentosa Trial in Baltimore (N-Acetyl Cysteine (NAC))

Completed
  • Retinitis Pigmentosa
  • N-Acetyl Cysteine (NAC)
  • Baltimore, Maryland
    Wilmer Eye Institute, Johns Hopkins
Sep 15, 2022

Refractory Metastatic Colorectal Cancer, pMMR, MSS Trial in United States (RP2, RP3, atezolizumab)

Not yet recruiting
  • Refractory Metastatic Colorectal Cancer
  • +2 more
  • RP2
  • +3 more
  • Los Angeles, California
  • +5 more
Feb 24, 2023

Advanced Solid Tumor Trial in Canada, Denmark, United States (RP-6306, RP-3500)

Recruiting
  • Advanced Solid Tumor
  • New Haven, Connecticut
  • +11 more
Apr 25, 2022

Knee Osteoarthritis, Post-traumatic Osteoarthritis, Rheumatoid Arthritis Trial in Linz (Cementless Vanguard DD RP)

Active, not recruiting
  • Knee Osteoarthritis
  • +2 more
  • Cementless Vanguard DD RP
  • Linz, Austria
    Kepler Universitäts Klinikum
Jul 1, 2022

Advanced Solid Tumor Trial in New York, Houston, Salt Lake City (RP-6306 (oral PKMYT1 inhibitor))

Recruiting
  • Advanced Solid Tumor
  • RP-6306 (oral PKMYT1 inhibitor)
  • New York, New York
  • +2 more
Jun 21, 2022

Advanced Solid Tumor Trial in United Kingdom (RP3, Nivolumab)

Recruiting
  • Advanced Solid Tumor
  • RP3
  • Nivolumab
  • Houston, Texas
  • +6 more
Jan 30, 2023

Cancer Trial in Spain, United Kingdom (RP2, nivolumab)

Recruiting
  • Cancer
  • RP2
  • nivolumab
  • Barcelona, Spain
  • +5 more
Nov 11, 2022

Solid Tumor, Metastatic Cancer Trial in United States (RP-3500, External Beam Radiotherapy (EBRT))

Recruiting
  • Solid Tumor
  • Metastatic Cancer
  • RP-3500
  • External Beam Radiotherapy (EBRT)
  • Basking Ridge, New Jersey
  • +6 more
Dec 8, 2022

Adult Solid Tumor Trial in Canada, United States (RP-6306 (oral PKMYT1 inhibitor))

Recruiting
  • Adult Solid Tumor
  • RP-6306 (oral PKMYT1 inhibitor)
  • Grand Rapids, Michigan
  • +4 more
May 17, 2022

Advanced Solid Tumor Trial in Worldwide (RP-3500, Talazoparib, Gemcitabine Injection [Gemzar])

Recruiting
  • Advanced Solid Tumor
  • Chicago, Illinois
  • +12 more
Nov 18, 2022

NSCLC Stage IV, NSCLC Stage IIIB, NSCLC Stage IIIC Trial in China (Cadonilimab, Anlotinib, Docetaxel)

Recruiting
  • NSCLC Stage IV
  • +2 more
  • Hefei, Anhui, China
  • +4 more
Apr 15, 2023

OCD Trial in New York, Philadelphia (Exposure & Response Prevention (EX/RP))

Recruiting
  • OCD
  • Exposure & Response Prevention (EX/RP)
  • New York, New York
  • +1 more
Jul 7, 2022

Multiple Myeloma Trial (RP followed by MPR)

Active, not recruiting
  • Multiple Myeloma
  • RP followed by MPR
  • (no location specified)
Mar 24, 2022

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial (RP7214)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • (no location specified)
Aug 17, 2022

Advanced Solid Tumor, Adult Trial in United States (RP-3500)

Recruiting
  • Advanced Solid Tumor, Adult
  • New Haven, Connecticut
  • +6 more
Mar 9, 2022